Myocardial Infarction Associated With Antihypertensive Drug Therapy

JAMA: The Journal of the American Medical Association

Volumn 275, Issue 7, 1996, Pages 515-516

  Cooper, Richard S ^a   Freeman, Vincent ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT;

CHEMICALLY INDUCED DISORDER; DELAYED RELEASE FORMULATION; DRUG UTILIZATION; HEALTH MAINTENANCE ORGANIZATION; HEART INFARCTION; HUMAN; NOTE; DRUG CONTRAINDICATION; HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DELAYED-ACTION PREPARATIONS; DRUG UTILIZATION; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MYOCARDIAL INFARCTION; HYPERTENSION;

EID: 13344270928     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1996.03530310021014     Document Type: Letter

References (4)

1. Psaty BM, Heckbert SR, Koepsell DS, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995;274:620-625.
2. Horton R. Spinning the risks and benefits of calcium antagonists. Lancet. 1995; 346:586-587.
3. Buring JE, Glynn RJ, Hennekens CH. Calcium channel blockers and myocardial infarction: a hypothesis formulated but not yet tested. JAMA. 1995;274:654-655.
4. Davis BR, Cutler IA, Gordon DJ, et al. Rationale and design of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Am J Hypertens. In press.